575 related articles for article (PubMed ID: 16831112)
1. Bupropion for the treatment of nicotine withdrawal and craving.
Mooney ME; Sofuoglu M
Expert Rev Neurother; 2006 Jul; 6(7):965-81. PubMed ID: 16831112
[TBL] [Abstract][Full Text] [Related]
2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
3. A comparison of sustained-release bupropion and placebo for smoking cessation.
Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
[TBL] [Abstract][Full Text] [Related]
4. Review of bupropion for smoking cessation.
Richmond R; Zwar N
Drug Alcohol Rev; 2003 Jun; 22(2):203-20. PubMed ID: 12850907
[TBL] [Abstract][Full Text] [Related]
5. Oxygen as a therapy for reducing nicotine withdrawal symptoms.
Granger RH
Med Hypotheses; 2005; 65(6):1161-4. PubMed ID: 16002232
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of nicotine addiction. Drug therapy for smoking cessation].
Pedersen ST; Christensen HR; Døssing M
Ugeskr Laeger; 2002 Mar; 164(11):1480-4. PubMed ID: 11924470
[TBL] [Abstract][Full Text] [Related]
7. Bupropion sustained release. A therapeutic review of Zyban.
Zwar N; Richmond R
Aust Fam Physician; 2002 May; 31(5):443-7. PubMed ID: 12043548
[TBL] [Abstract][Full Text] [Related]
8. The effect of bupropion on nicotine craving and withdrawal.
Shiffman S; Johnston JA; Khayrallah M; Elash CA; Gwaltney CJ; Paty JA; Gnys M; Evoniuk G; DeVeaugh-Geiss J
Psychopharmacology (Berl); 2000 Jan; 148(1):33-40. PubMed ID: 10663415
[TBL] [Abstract][Full Text] [Related]
9. [Bupropion. An antidepressant used to help smoking cessation].
Taeron C
Rev Infirm; 2002 May; (81):47-9. PubMed ID: 12078615
[No Abstract] [Full Text] [Related]
10. Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease.
Joseph AM; Fu SS
Prog Cardiovasc Dis; 2003; 45(6):429-41. PubMed ID: 12800126
[TBL] [Abstract][Full Text] [Related]
11. Bupropion sustained release and smoking cessation.
Goldstein MG
J Clin Psychiatry; 1998; 59 Suppl 4():66-72. PubMed ID: 9554323
[TBL] [Abstract][Full Text] [Related]
12. Effect of glucose on tobacco withdrawal symptoms in recent quitters using bupropion or nicotine replacement.
McRobbie H; Hajek P
Hum Psychopharmacol; 2004 Jan; 19(1):57-61. PubMed ID: 14716714
[TBL] [Abstract][Full Text] [Related]
13. Advances in pharmacotherapy for tobacco dependence.
Foulds J; Burke M; Steinberg M; Williams JM; Ziedonis DM
Expert Opin Emerg Drugs; 2004 May; 9(1):39-53. PubMed ID: 15155135
[TBL] [Abstract][Full Text] [Related]
14. Amfebutamone/bupropion for smoking cessation: new preparation. Nicotine replacement therapy is safer.
Prescrire Int; 2001 Dec; 10(56):163-7. PubMed ID: 11824437
[TBL] [Abstract][Full Text] [Related]
15. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
16. Effect of stress and bupropion on craving, withdrawal symptoms, and mood in smokers.
Kotlyar M; Drone D; Thuras P; Hatsukami DK; Brauer L; Adson DE; al'Absi M
Nicotine Tob Res; 2011 Jun; 13(6):492-7. PubMed ID: 21378081
[TBL] [Abstract][Full Text] [Related]
17. Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
Wing VC; Shoaib M
Psychopharmacology (Berl); 2007 Dec; 195(3):303-13. PubMed ID: 17690868
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
19. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
David SP; Niaura R; Papandonatos GD; Shadel WG; Burkholder GJ; Britt DM; Day A; Stumpff J; Hutchison K; Murphy M; Johnstone E; Griffiths SE; Walton RT
Nicotine Tob Res; 2003 Dec; 5(6):935-42. PubMed ID: 14668077
[TBL] [Abstract][Full Text] [Related]
20. Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials.
Shiffman S; West R; Gilbert D;
Nicotine Tob Res; 2004 Aug; 6(4):599-614. PubMed ID: 15370156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
